Steadymed Therapeutics
United Therapeutics is a pioneering biotechnology company dedicated to developing innovative therapies and creating an unlimited supply of transplantable organs. With a patient-driven mission, the company focuses on addressing unserved needs in organ disease treatment and advancing regenerative medicine. It operates as a public benefit corporation, emphasizing sustainability, patient safety, and social responsibility. The company has a rich history of scientific achievement, strategic collaborations, and recognition as a great place to work, committed to improving patient outcomes and fostering a supportive work environment.
Industries
Nr. of Employees
small (1-50)
Steadymed Therapeutics
1000 Spring Street, Silver Spring, Maryland 20910
Products
Therapies and delivery systems for pulmonary vascular disease
Portfolio of therapeutic products and associated delivery systems developed for pulmonary vascular diseases, spanning inhalation, oral extended-release, and pump-delivered formulations.
Monoclonal antibody oncology therapy
Development and commercialization of a monoclonal antibody therapy for high-risk pediatric oncology indications developed in collaboration with clinical research partners.
Therapies and delivery systems for pulmonary vascular disease
Portfolio of therapeutic products and associated delivery systems developed for pulmonary vascular diseases, spanning inhalation, oral extended-release, and pump-delivered formulations.
Monoclonal antibody oncology therapy
Development and commercialization of a monoclonal antibody therapy for high-risk pediatric oncology indications developed in collaboration with clinical research partners.
Services
Provision of ex-vivo organ perfusion procedures and operation of a lung restoration center in collaboration with clinical partners to assess and restore donor lungs for transplant.
Research collaborations and joint development programs for organ bioprinting, scaffold manufacturing, and regenerative medicine aimed at producing transplantable organs.
Provision of ex-vivo organ perfusion procedures and operation of a lung restoration center in collaboration with clinical partners to assess and restore donor lungs for transplant.
Research collaborations and joint development programs for organ bioprinting, scaffold manufacturing, and regenerative medicine aimed at producing transplantable organs.
Expertise Areas
- Organ biomanufacturing and regenerative medicine
- Xenotransplantation program development
- Pulmonary hypertension therapeutics and clinical development
- Drug formulation and drug‑device combination development
Key Technologies
- Ex-vivo lung perfusion
- 3D bioprinting of organ scaffolds
- Regenerative medicine laboratory processes
- Xenotransplantation platforms